Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia
И. Ф. Беленичев(Zaporizhzhia State Medical and Pharmaceutical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Valentyn Oksenych(University of Bergen), Dmytrо Savchenko(Bogomolets National Medical University), Kristina Burlaka(Zaporizhzhia State Medical and Pharmaceutical University), E. Aliyeva(Zaporizhzhia State Medical and Pharmaceutical University), Oleh KUCHKOVSKYI(Zaporizhzhia State Medical and Pharmaceutical University), Б. С. Бурлака(Zaporizhzhia State Medical and Pharmaceutical University)
Cited by 1
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48